# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-22-014474
Filing Date
2022-04-14
Accepted
2022-04-14 16:30:46
Documents
3
Period of Report
2022-05-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | hrtx-pre14a_20220616.htm | PRE 14A | 2444767
2 | GRAPHIC | gwr1thvryjya000002.jpg | GRAPHIC | 370660
3 | GRAPHIC | gwr1thvryjya000001.jpg | GRAPHIC | 583535
| Complete submission text file | 0001564590-22-014474.txt |  | 3760247

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33221 | Film No.: 22827666
SIC: 2834 Pharmaceutical Preparations